STRUCTURED EQUITY

摘要

Swedish biotech services company CELLINK raised SKr3bn (US$352m) on Thursday evening from a combined offering of five-year convertible bonds and an upsized 6.9% capital increase. Proceeds will finance acquisitions, including the US$68m cash-and-shares acquisition of US in-vitro technology firm MatTek announced on Wednesday.